Drugmaker Eyes Ch. 11 Pivot In Bid To Stave Off Liquidation
DMK Pharmaceuticals told a Delaware bankruptcy judge Tuesday that it aims to stay financially afloat by narrowing its focus to drugs to combat the opioid crisis, but it won't know for...To view the full article, register now.
Already a subscriber? Click here to view full article